Skip to main content

Animations

MJFF Publications

2371 - 2380 of 6564 Results
Title
Year
  • Year
  • 2014
  • 2025
  • 2020
  • 2016
  • 2026
  • 2025
  • 2025
  • 2018
  • 2021
  • 2011
  • Summary Details
    OPEN
    Title: RETRACTED: ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo
    Journal Name: Molecular Therapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1038/mt.2014.129
    Citation Count: 82
  • Summary Details
    OPEN
    Title: Amygdala Neurodegeneration: A Key Driver of Visual Dysfunction in Parkinson's Disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.70007
    Citation Count: 4
  • Summary Details
    OPEN
    Title: NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1909110117
    Citation Count: 147
  • Summary Details
    OPEN
    Title: Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.338
    Citation Count: 617
  • Summary Details
    OPEN
    Title: Study of blood linear RNA nominates CD55 and DLD as early-stage biomarkers for Parkinson's disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awag014
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Diagnostic and other biomarkers of dementia with Lewy bodies: from research to clinical settings
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(25)00314-x
    Citation Count: 11
  • Summary Details
    OPEN
    Title: A single-cell atlas to map sex-specific gene-expression changes in blood upon neurodegeneration
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-025-56833-7
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-018-1337-8
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/jev2.12182
    Citation Count: 351
  • Summary Details
    OPEN
    Title: Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System Atrophy
    Journal Name: The American Journal of Pathology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ajpath.2011.01.006
    Citation Count: 123
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.